Kialo requires cookies to work correctly.
Medical research should embrace racial differences in treatment efficacy
Research companies may prioritise/discontinue their research based upon racial discrimination.
If a pharmaceutical company is profit driven and finds that a particular disease is more prevalent in people of colour, they may not invest as much in producing a drug to treat the disease as they could feel they won't be able to profit as much due to income
There is evidence that patterns in prescriptions and drug development have reflected racial biases. It is plausible to assume that these patterns will persist as racially specific medical treatments further develop.
It is likely companies that showed any sort of preference in research that was racially biased would receive strong criticism.
Race based medicines are often
at groups which are subjected to discrimination.
The existence of large profit incentives is sufficient to motivate pharmaceuticals to produce drugs for marginalized groups.